JGC
NPTN

J. Goldman & Co’s NEOPHOTONICS CORP NPTN Stock Holding History

J. Goldman & Co’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-363,402
Closed -$3.17M – 489
2021
Q3 		$3.17M Sell
363,402
-146,397
-29% -$1.33M 0.16% 152
2021
Q2 		$5.21M Buy
509,799
+465,111
+1,041% +$4.91M 0.2% 128
2021
Q1 		$534K Buy
+44,688
New +$507K 0.02% 356
2018
Q1 		– Sell
-8,580
Closed -$56K – 466
2017
Q4 		$56K Sell
8,580
-526,520
-98% -$3.22M ﹤0.01% 309
2017
Q3 		$2.98M Buy
+535,100
New +$3.61M 0.15% 167

Other funds holding NPTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

J. Goldman & Co's NPTN Position: Q4 2021 in Review

J. Goldman & Co sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 363,402 shares — an estimated $3.17M sold.

J. Goldman & Co first reported a position in NPTN in Q3 2017 and held it in 5 quarters. The position peaked at $5.21M in Q2 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • J. Goldman & Co reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • J. Goldman & Co sold 363,402 NEOPHOTONICS CORP shares in Q4 2021, an estimated $3.17M.
  • J. Goldman & Co first reported a position in NEOPHOTONICS CORP in Q3 2017 and held it in 5 quarters.
  • J. Goldman & Co's NEOPHOTONICS CORP position peaked at $5.21M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.